Sam Eiber
Stock Analyst at BTIG
(1.66)
# 3,497
Out of 5,237 analysts
17
Total ratings
33.33%
Success rate
-5.38%
Average return
Main Sectors:
Stocks Rated by Sam Eiber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Maintains: Buy | $88 → $90 | $71.50 | +25.87% | 6 | May 7, 2026 | |
| APYX Apyx Medical | Upgrades: Buy | $6 | $3.92 | +53.06% | 2 | Mar 11, 2026 | |
| SBC SBC Medical Group Holdings | Initiates: Buy | $8 | $3.16 | +153.16% | 1 | Mar 6, 2026 | |
| EOLS Evolus | Reiterates: Buy | $13 | $6.32 | +105.70% | 5 | Mar 4, 2026 | |
| MMSI Merit Medical Systems | Initiates: Buy | $107 | $60.31 | +77.42% | 1 | Feb 6, 2026 | |
| INMD InMode | Downgrades: Neutral | n/a | $13.77 | - | 2 | Apr 29, 2025 |
Establishment Labs Holdings
May 7, 2026
Maintains: Buy
Price Target: $88 → $90
Current: $71.50
Upside: +25.87%
Apyx Medical
Mar 11, 2026
Upgrades: Buy
Price Target: $6
Current: $3.92
Upside: +53.06%
SBC Medical Group Holdings
Mar 6, 2026
Initiates: Buy
Price Target: $8
Current: $3.16
Upside: +153.16%
Evolus
Mar 4, 2026
Reiterates: Buy
Price Target: $13
Current: $6.32
Upside: +105.70%
Merit Medical Systems
Feb 6, 2026
Initiates: Buy
Price Target: $107
Current: $60.31
Upside: +77.42%
InMode
Apr 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $13.77
Upside: -